Keywords: UK, Regenerative medicines, Funding, BIA, ABPI appointment

UK government funding for regenerative medicines supports BIGT goals; executive change at ABPI

Article | 08 January 2010

The first three state-of-the-art manufacturing research centers – including one impacting on biotechnology - funded under a new £70 million ($113 million) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in